IMMUNIC, INC. - Common Stock (IMUX)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Shares outstanding
120,284,725
Total 13F shares
9,296,231
Share change
-410,738
Total reported value
$148,180,917
Put/Call ratio
60%
Price per share
$15.94
Number of holders
58
Value change
-$6,245,917
Number of buys
22
Number of sells
33

Institutional Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q1 2021

As of 31 Mar 2021 IMMUNIC, INC. - Common Stock (IMUX) had 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 9,296,231 shares of stock of the company.
Largest 10 holders included Omega Fund Management, LLC, FMR LLC, RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, Artal Group S.A., Point72 Asset Management, L.P., Parkman Healthcare Partners LLC, Ghost Tree Capital, LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 58 institutional shareholders of the security as of 31 Mar 2021.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.